|
Market Closed -
Nasdaq Stockholm
02:00:00 28/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 1.800 SEK | +2.27% |
|
-7.46% | -5.26% |
| 09:51pm | Enzymatica expands group management with two executives | FW |
| 20/07 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| Market Cap | 427M 367M 343M 314M 592M 40.8B 594M 4.07B 1.59B 20.56B 1.6B 1.57B 68.06B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 395M 339M 318M 291M 548M 37.74B 549M 3.76B 1.47B 19.02B 1.48B 1.45B 62.94B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.27% | ||
| 1 week | -7.46% | ||
| Current month | -2.96% | ||
| 1 month | -2.70% | ||
| 3 months | -34.78% | ||
| 6 months | -5.01% | ||
| Current year | -5.26% |
| 1 week | 1.74 |  | 1.94 |
| 1 month | 1.74 | | 2.1 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 01/01/2011 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/7/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% | ||
| 27/12/25 | Buy | Chairman | 5,500 | 0.0023% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.27% | -7.46% | -23.73% | -33.82% | 44.81M | |
| -0.04% | -4.48% | +61.90% | +114.59% | 1,060B | |
| -1.18% | -0.20% | +50.94% | +62.42% | 651B | |
| -1.72% | -1.40% | +24.08% | +75.11% | 465B | |
| -1.17% | -2.10% | +38.61% | +40.46% | 365B | |
| -2.00% | -1.35% | +22.22% | +37.78% | 300B | |
| -0.98% | +0.53% | +2.04% | +12.13% | 258B | |
| -0.39% | +1.23% | +52.46% | +71.14% | 238B | |
| -3.18% | -0.30% | -17.23% | -54.33% | 210B | |
| +0.23% | +3.42% | +30.22% | +92.56% | 184B | |
| Average | -0.77% | -1.55% | +24.15% | +41.80% | 373.05B | |
| Weighted average by Cap. | -0.93% | -2.16% | +39.05% | +66.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 39.12M 36.63M 33.54M 63.18M 4.35B 63.36M 434M 170M 2.19B 171M 167M 7.26B | 53.9M 46.27M 43.32M 39.67M 74.72M 5.15B 74.94M 513M 201M 2.59B 202M 198M 8.59B |
| Net income | -53.18M -45.65M -42.74M -39.13M -73.72M -5.08B -73.93M -506M -198M -2.56B -200M -195M -8.47B | -51.89M -44.54M -41.7M -38.19M -71.93M -4.96B -72.14M -494M -193M -2.5B -195M -191M -8.27B |
| Net Debt | -73.01M -62.67M -58.68M -53.73M -101M -6.97B -101M -695M -272M -3.51B -274M -268M -11.63B | -32.11M -27.56M -25.81M -23.63M -44.51M -3.07B -44.64M -306M -119M -1.55B -121M -118M -5.12B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | SEK 1.800 | +2.27% | 52,304 |
| 26/08/26 | SEK 1.760 | -7.37% | 177,342 |
| 25/08/26 | SEK 1.900 | +2.70% | 1,530 |
| 24/08/26 | SEK 1.850 | -0.54% | 61,865 |
| 21/08/26 | SEK 1.860 | -3.38% | 79,098 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
